Serotonin neurons integrate GABA and dopamine inputs to regulate meal initiation
- PMID: 39667432
- PMCID: PMC11924950
- DOI: 10.1016/j.metabol.2024.156099
Serotonin neurons integrate GABA and dopamine inputs to regulate meal initiation
Abstract
Obesity is a growing global health epidemic with limited orally administered therapeutics. Serotonin (5-HT) is one neurotransmitter which remains an excellent target for new weight-loss therapies, but a gap remains in understanding the mechanisms involved in 5-HT produced in the dorsal Raphe nucleus (DRN) and its involvement in meal initiation. Using an optogenetic feeding paradigm, we showed that the 5-HTDRN➔arcuate nucleus (ARH) circuit plays a role in meal initiation. Incorporating electrophysiology and ChannelRhodopsin-2-Assisted Circuit Mapping, we demonstrated that 5-HTDRN neurons receive inhibitory input partially from GABAergic neurons in the DRN, and the 5-HT response can be enhanced by hunger. Additionally, deletion of the GABAA receptor subunit in 5-HT neurons inhibits meal initiation with no effect on the satiation process. Finally, we identified the role of dopaminergic inputs via dopamine receptor D2 in enhancing the response to GABA-induced feeding. Thus, our results indicate that 5-HTDRN neurons are inhibited by synergistic inhibitory actions of GABA and dopamine, for the initiation of a meal.
Keywords: Dopamine; GABA; Meal initiation; Serotonin.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures
Update of
-
5-HT Neurons Integrate GABA and Dopamine Inputs to Regulate Meal Initiation.bioRxiv [Preprint]. 2024 Apr 29:2024.04.26.591360. doi: 10.1101/2024.04.26.591360. bioRxiv. 2024. Update in: Metabolism. 2025 Feb;163:156099. doi: 10.1016/j.metabol.2024.156099. PMID: 38746314 Free PMC article. Updated. Preprint.
References
-
- Flier JS, Obesity wars: molecular progress confronts an expanding epidemic. Cell 116, 337–350 (2004). - PubMed
-
- Correia ML, Rahmouni K, Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome. Diabetes Obes Metab 8, 603–610 (2006). - PubMed
-
- Lechin F, van der Dijs B, Hernández-Adrián G, Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: relevance for neuropharmacological therapy. Prog Neuropsychopharmacol Biol Psychiatry 30, 565–585 (2006). - PubMed
-
- Rowland NE, Carlton J, Neurobiology of an anorectic drug: fenfluramine. Prog Neurobiol 27, 13–62 (1986). - PubMed
-
- Connolly HM et al. , Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 337, 581–588 (1997). - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous
